BUZZ-Amneal rises after US FDA nod for generic asthma inhaler
Shares of drugmaker Amneal Pharmaceuticalsrise 1.2% to $12.45 premarketCo says U.S. FDA approved its generic version of a widely used asthma drug, albuterol sulfate inhalation aerosolApproval comes after FDA cleared co’s generic version of Teva’s (TEVA.TA) QVAR inhaler for asthma - AMRXCo says both approvals mark progress in complex respiratory drug marketUp to last close, stock up ~55% YTD
Shares of drugmaker Amneal Pharmaceuticals (AMRX.O) rise 1.2% to $12.45 premarket
Co says U.S. FDA approved its generic version of a widely used asthma drug, albuterol sulfate inhalation aerosol
Approval comes after FDA cleared co’s generic version of Teva’s (TEVA.TA) QVAR inhaler for asthma - AMRX
Co says both approvals mark progress in complex respiratory drug market
Up to last close, stock up ~55% YTD
